Using a Pharmacology to Payer Framework to Support Product Development
Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…
CertaraMarch 16, 2018
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions
Analogous to how a geologist surveys the “lay of the land” to determine if oil…
CertaraFebruary 16, 2018
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal
Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…
CertaraAugust 24, 2017
Investigational Drug Gap Analysis
As the process of drug development has increased in cost and complexity, Certara has developed…
CertaraAugust 14, 2017
Clinical Pharmacology—The Quarterback of Drug Development
Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…
CertaraAugust 14, 2017
